Brexit may affect the cost of medicines and hit UK pharmaceutical investment, a Commons committee head has warned. Rachel Reeves, who chairs the Business, Energy and Industrial Strategy (BEIS ...

50% believe that Brexit has impacted the attractiveness of the UK pharma market; 44% believe that Brexit makes the UK market less ... she believed it was the ‘fillip’ to the impact of Brexit.

This past Friday, GEN covered the news that the U.K. had voted to leave the European Union: “Keeping a Stiff Upper Lip Despite Brexit.” GEN subsequently asked a number of biotech scientists ...

Infiniti, a leading market intelligence solutions provider, has announced the launch of their latest article on illuminating the impact of Brexit on Europe’s pharmaceutical industry. Brexit can ...

Brexit and the Healthcare Industry - Implications for Pharma, Q3 2018: Key Factors to Impact the Post-Brexit UK Healthcare Industry Providing Respondent Mix by Region and Seniority Level ...

It would even impact drug prices as reference pricing schemes throughout the E.U. would need to be altered. In brief, a no-deal Brexit would imply an ... pharmaceutical firms may for this ...

[9] BREXIT EFPIA survey results of 8 November 2017, European Federation of Pharmaceutical Industries and Associations. [10] No. 4 of EMA Guidance. [11] No. 4c of EMA Guidance.

The volatility has enlivened what has been a slow year for biotech and pharma stocks, which took a hit in the first weeks of 2016. ... concerns about how Brexit would impact regulation, tax ...

The impact of Brexit on the pharmaceutical industry has yet to be determined, but some fear that Brexit will cause the UK to lag behind in the biosimilar sphere in particular.

Brexit may affect the cost of medicines and hit UK pharmaceutical investment, a Commons committee head has warned. Rachel Reeves, who chairs the Business, Energy and Industrial Strategy (BEIS ...

Rachel Reeves says uncertainty about Brexit is "very concerning" for the UK pharmaceutical industry.